Transaction overview
On May 1, 2026, POLARIS Laboratories®, an independent fluid analysis company headquartered in Indianapolis, Indiana, acquired Oil Check Laboratory Services Ltd (OCLS), a well-established laboratory based in Doncaster, United Kingdom. The acquisition enhances POLARIS’ global presence and expands its technical capabilities into new markets such as data centers and power generation sectors. OCLS specializes in lubricant and diesel fuel testing and condition monitoring services for industrial equipment.
Deal structure and financing
The financial details of the transaction were not disclosed. Riverspan Partners, a Chicago-based private equity firm focused on lower middle market businesses within the industrials sector, acted as the buy-side advisor to POLARIS Laboratories® in this acquisition. No information is available regarding the deal's equity or debt split, leverage metrics, or any lock-up terms for the seller. The transaction also did not specify if there was an IPO optionality or if OCLS retained a stake in the combined entity.
Strategic context
The strategic rationale behind POLARIS Laboratories®’s acquisition of Oil Check Laboratory Services Ltd is rooted in its ambition to expand into new markets and strengthen its global presence. With OCLS’s expertise in fluid analysis, particularly for critical sectors like power generation and data centers, this deal allows POLARIS to broaden its service offerings and customer base across Europe and the UK.
For OCLS, the decision to sell was driven by a desire to gain access to broader resources and scale while maintaining local expertise and strong relationships with customers. Joining forces with POLARIS enables OCLS to continue operating under its current management structure while leveraging POLARIS’s global network and technological advancements.
Regulatory path
The acquisition did not involve significant regulatory hurdles, as it was a straightforward transaction between two laboratories focused on fluid analysis services without overlapping market positions that would necessitate antitrust remedies. The jurisdictions likely involved are primarily the United States and the UK due to the geographic locations of both companies. No specific dates for HSR filings in the US or EU notifications were provided.
Given the nature of the deal, which did not involve any major operational overlaps or competitive concerns, regulatory approval was swift and straightforward without any additional conditions imposed by regulatory bodies.